Somanetics Corp. falls on downgrade
Shares of Somanetics Corp. (Nasdaq: SMTS) are falling following news before the start of trading that the Troy, Mich.-based maker of a non-invasive patient monitoring system was downgraded to “reduce” from “neutral” by investment bank SunTrust Robinson Humphrey. At 2:02 p.m. ET, the stock was down $6.28, or 25%, to $18.86.
For detailed price information and recent news stories about Somanetics, click SMTS.
